TABLE 2.
NFOG‐Q | ||
---|---|---|
Pearson's correlation (γ) | p‐Value | |
Age (years) | 0.149 | .379 |
Age at disease onset (years) | 0.144 | .392 |
Duration of disease (years) | 0.089 | .598 |
Levodopa equivalent dose (mg) | −0.040 | .816 |
H‐Y stage | 0.597 | <.0001 |
Tremor subscore | 0.032 | .850 |
Rigidity subscore | 0.164 | .333 |
Bradykinesia subscore | 0.413 | .0111 |
PIGD subscore | 0.639 | <.0001 |
UPDRS part I score | 0.495 | .002 |
UPDRS part II score | 0.233 | .0007 |
UPDRS part III score | 0.405 | .0129 |
UPDRS part IV score | 0.496 | .0018 |
PDQ‐39 score | 0.624 | <.001 |
NMSS score | 0.356 | .0307 |
MoCA score | 0.450 | .0052 |
HAM‐A score | 0.369 | .0244 |
HAMD score | 0.451 | .0051 |
ESS score | 0.198 | .239 |
AHRS score | −0.034 | .842 |
RBD‐SQ score | 0.381 | .0199 |
SCPA‐AUT score | 0.158 | .349 |
Abbreviations: ESS, Epworth Sleepiness Scale; H‐Y stage, Hoehn‐Yahr stage; HAM‐A, Hamilton Anxiety Scale; HAMD, Hamilton Depression Scale; NMSS, nonmotor symptoms assessment scale; MoCA, Montreal Cognitive Assessment; PDQ‐39, Parkinson's disease questionnaires‐39; PIGD, postural instability gait difficulty; UPDRS, Unified Parkinson's Disease Rating Scale.